Swedish Orphan Biovitrum appoints Anders Edvell as new Head of Sales and Marketing

05-Nov-2010 - Sweden

Swedish Orphan Biovitrum announced that Anders Edvell has been appointed new VP of Marketing & Sales in Sobi. He will be the successor of Kennet Rooth, as he leaves his position January 10, 2011 for personal reasons.

Anders Edvell is an MD and PhD in medicine, and has an MBA degree from the Stockholm School of Economics. Anders has held several positions in the pharmaceutical industry, nationally as well as internationally. He joined Swedish Orphan International in August 2006 as Country Manager for Sweden and has, since March 2010, acted as Northern European Regional Director at Sobi. Furthermore, he has also from time to time been significantly involved the business development of Swedish Orphan International.

Other news from the department people

Most read news

More news from our other portals

Last viewed contents

Dharmacon's completion of first human genome-wide siRNA library signals new era in life-science research

Sequenom and NAFTNet to Conduct Fetal Rhesus D Study in Collaboration with Baylor College of Medicine

LFE Laboratorium für industrielle Forschung GmbH & Co. Entwicklungs KG - Bruchköbel, Germany

LFE Laboratorium für industrielle Forschung GmbH & Co. Entwicklungs KG - Bruchköbel, Germany

Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Trials for DiaPep277 for Type 1 Diabetes

Bonnie Bassler and Martin Wikelski receive Max Planck Research Award - Scientists honoured for their pioneering research into the sensory perception of organisms

Bonnie Bassler and Martin Wikelski receive Max Planck Research Award - Scientists honoured for their pioneering research into the sensory perception of organisms

Stora Enso and Gasum to make renewable energy from wastewater in Sweden

LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria

LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration

Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe

Eschbach receives the Best of Industry Award for Artificial Intelligence for the second time in a row - "AI technologies are increasingly becoming an integral part of process management..."

Eschbach receives the Best of Industry Award for Artificial Intelligence for the second time in a row - "AI technologies are increasingly becoming an integral part of process management..."

Antibiotic-Resistant Bacteria Have Evolved a Unique Chemical Mechanism, New Discovery Reveals